µand m-calpain are ubiquitously expressed in most cells and particularly abundant in muscle cells. Knockout of calpain-1 (catalytic subunit of µ-calpain) induced moderate platelet dysaggregation preserving the normal development and growth, though knockout of calpain-2 (m-calpain) is lethal in mice. Therefore, there should be muscle-specific function of m-calpain per se. Previous methods lack direct evidence for the involvement of m-calpain, because the specific inhibitor to m-calpain has not been developed yet and the inhibition was less potent. Here, we show that screened RNAi specifically blocked the m-calpain expression by 95% at both the protein and the activity levels. After transfecting adenovirus vector-mediated cDNA corresponding to the RNAi-induced shRNA, m-calpain in C 2 C 12 myoblasts was knocked down with no compensatory overexpression of µ-calpain or calpain-3. The specific knockdown strongly inhibited the fusion to multinucleated myotubes. In addition, the knockdown modestly blocked ubiquitous effects, including cell-migration, spreading and alignment of central stress fiber-like structures. These results may indicate that m-calpain requiring millimolar Ca 2+ level for the full activation plays specific roles in myogenesis, independent of µ-calpain, and leave us challenging problem in future.
Introduction
Calpains form a superfamily of Ca 2+ -activated cytosolic cystein proteases widely distributed from mammals to invertebrates. The conventional calpains (µ-and m-calpain) are composed of heterodimer with each catalytic subunit, encoded by calpain-1 (Capn1) or calpain-2 (Capn2), and a common regulatory subunit encoded by calpain-4 (Capn4). Calpain activity is regulated by a variety of factors, including Ca 2+ , phospholipids, the small subunit, an endogenous calpain-specific inhibitor peptide; calpastatin, autodigestion and phosphorylation via the ERK/MAP pathway (21, 40) . Calpain family has been implicated in a large number of physiological processes including cell spreading, cell migration, myoblast fusion, cell cycle and apoptosis (21) , and various pathological processes such as neuromuscular diseases, cardiac dysfunction, cataract and diabetes (24, 27, 43, 50) . Skeletal and cardiac muscles contain large amounts of µand m-calpain that may contribute to the progression of muscular dystrophy and/or advanced heart failure (12, 44, 48) , though the lack of a specific inhibitor for each calpain has made verification of each role difficult.
Transgenic animals are of a great use for uncovering the physiological function of novel proteins and clarifying the molecular mechanism of several diseases, developing a new strategy for the treatment.
The knockout mice are, however, limited by the resultant developmental effects, genetic compensation and lack of specificity, not at the whole animal level but at the cellular and/or organ level. In the case of Capn2, the homozygous disruption of the gene showed preimplantation lethality, indicating that this protease is indispensable for early embryogenesis (16) . Here, we used RNA interference (RNAi) to generate a specific knockdown of Capn2 at the cellular level.
A major challenge in applying this technique in vitro or in vivo has been addressed by introducing the siRNA (small interfering RNA) and short hairpin RNA (shRNA) into primary cultures or into target cells of higher living organisms (18, 29, 47, 49) .
We generated Capn2 knockdown of skeletal myoblast cell line, C 2 C 12 , using an efficient adenovirus-mediated RNAi (37) and demonstrated clear evidence that m-calpain is involved in fusion of myoblasts to myotubes, in addition to other aspects of myogenesis.
Materials and methods
Materials -Anti-m-calpain antibody was kindly supplied by Dr bottom, 5'-AAAACTACACAAATCA GCGATTTTTCGAAATCGCTGATTTGTGTAGC -3').
These oligonucleotides were annealed and cloned into pENTR TM /U6 vector according to manufacturer's instructions. All clones were verified by direct sequencing. The U6 promoter, hairpin sequence and terminator sequences were ligated into a pAd/BLOCK -it TM DEST vector. Adenovirus expression plasmids were digested with Pac I to expose the inverted terminal repeats (ITRs) and
transfected into the 293A producer cells using Lipofectamine TM 2000 (Invitrogen) to produce adenovirus stock. Amplified adenovirus was used to knockdown calpain-2, and the enzyme expression was analyzed by Western blot and casein zymography, for verification of the expression at the protein and activity levels, respectively, as described below.
Quantitative mRNA assay -The quantity of mRNA from cultured cells was measured with a branched DNA signal amplification assay (Quantigene® High Volume bDNA Signal Amplification Kit, Panomics, Fremont, CA), following the manufacturer's instructions. The premises for this assay have been extensively described by Hartley and Klaassen (22) .
Western blot -Protein levels of m-calpain large subunit andP -tubulin in C 2 C 12 myoblasts and myotubes 7 were measured as described previously (38, 42) . Protein concentrations were determined by Bradford's method (9) . After washing the blotted membrane with the Tween-20/PBS, reacted bands were detected using horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG (DAKO, Glostrup, Denmark) with ECL (GE Healthcare Bio-Sciences, Piscataway, NJ).
Calpain activity assay -Both µand m-calpain activities in cell extracts were simultaneously measured by casein zymography in a non-denaturing system (35) .
Immunofluorescence microscopy -C 2 C 12 myoblasts grown on Lab-Tek II chamber slides (Nalge Nunc international, Rochester, NY) were double stained with Alexa Fluor ® 594-labeled phalloidin for actin and FITC-labeled specific antibody to vinculin (26, 38) . After washing with PBS, the specimens were examined with a confocal laser scanning microscope (LSM410, Carl Zeiss Inc., Oberkochen, Germany).
Cell motility assay -C 2 C 12 myoblasts were tested for their ability to move into a denuded area on the culture dish (Nalge Nunc international). Phase contrast pictures were taken at 0 and 24 h and the cell migration was determined by the distance moved into the acellular area over time.
Spreading assay -Cell morphology was examined by fluorescent microscopy and optical microscopy, and the number of cells presenting visible cytoplasm or not was determined by visual inspection on Lab-Tek II chamber slides (Nalge Nunc international). The rate of spreading was defined as the number of cells with visible cytoplasm/total number of cells × 100 (28) .
Statistical Analysis -For the quantitative assay, the difference among the Ad_shSCR and Ad_shcapn2 transfected cells was evaluated by the Student's t test. A p value less than 5% was considered to be significant.
Results

Expressions of m-calpain large subunit (calpain-2) mRNA and protein during C 2 C 12 myogenesis
To determine the expression level of calpain-2 at different stages of myogenesis, we quantified it at both mRNA and protein levels in mouse C 2 C 12 . Cells were extracted at the subconfluency (day minus 1) and confluency (day 0) from the GM cultures and at various stages after the induction of cell 
Suppression of calpain-2 by adenovirus vector-mediated RNAi in C 2 C 12
It was difficult to effectively transfect synthetic siRNA or siRNA-expressing plasmids in myoblasts, myotubes and myocytes. For the complete expression of siRNA to Capn2 in C 2 C 12 myoblasts, the adenovirus vector was very useful, because the transfection efficiency reached nearly 100% (4). The adenovirus-mediated RNAi was generated by expressing U6 promoter-driven shRNA (Ad_shcapn2), which targets Capn2, as well as the control vector with a scrambled sequence (Ad_shSCR). At 3 day 10 after the transfection, C 2 C 12 cells expressing Capn2-RNAi showed an apparent reduction of calpain-2 protein level ( Fig. 2A ). To simultaneously assess both activities of µand m-calpain in the knockdown cells at 3 days after transfection, casein zymography was carried out. Both enzyme activities were observed in Ad_shSCR-transfected cells, but the knockdown showed only µ-calpain activity with no m-calpain activity (Fig. 2B ).
Additionally, to assess the continuous reduction of RNAi-mediated calpain-2, we followed the time course of calpain-2 level up to day 9 after transfection and found that the expressed amount gradually recovered in the post-transfection period (Fig. 2C ). This reversal may reflect a transient action after the target gene delivery. However, these data demonstrate the potential to suppress calpain-2 with
Ad_shcapn2. The activity of calpain-3 specifically contained in skeletal muscle (30) was not detected at all in the current zymography. It should be noted that no compensatory expression of µ-calpain large subunit (calpain-1) was detected during the suppression of calpain-2. The m-calpain activity of cells transfected Ad_shcapn2 decreased to 5-27% (p < 0.0005), compared with that with Ad_shSCR on day 3 to 7 after the transfection ( Fig. 2B , C). However, at that time, no significant difference was observed in the activity of µ-calpain between Ad_shSCR and Ad_shcapn2 (p > 0.05, Fig. 2D ). On day 9 after the transfection, the knockdown efficiency recovered up to 40% and the activity of µ-calpain slightly increased, compared with Ad_shSCR (p = 0.045, Fig. 2D ).
Cell detachment during the differentiation of Capn2 knockdown
Myoblasts were at first grown in the GM, and then induced to differentiate by switching to the DM.
The alignment of myoblasts started from day 3 to 4, followed by the fusion to multinucleated myotubes between day 5 and 7. Previous reports postulated that m-calpain was essential for myoblast differentiation to myotubes via the limited digestion of membrane-proteins (25) . We examined whether knockdown of Capn2 inhibits the myoblast fusion and/or differentiation to myotubes. On day 3 after the transfection when these cells reached the confluency, we started the differentiation. Myoblasts transfected with Ad_shSCR became aligned and started to fuse on day 3 after the induction of differentiation. However, those cells transfected with Ad_shcapn2 did not fuse ( Fig. 3A, B ).
Furthermore, Capn2 knockdown cells had changed morphology and diminished adhesiveness, resulting in numerous detachments from the dish (Fig. 3C ).
Inhibition of myoblast fusion to multinucleated myotubes with the selective knockdown of Capn2
Because the duration of adenovirus-vector mediated expression of both the transcript and the transgene is transient, the permanent knockdown is not expected. Actually, the knockdown was restored from day 7 after the transfection (Fig. 2C ). For an exact assessment of the inhibitory effect of RNAi, it is necessary for evaluating myoblast differentiation to keep the high knockdown activity. We repeated the transfection on day 3 after the initial treatment. Then, we counted the number of myotubes that was defined as the cell with at least three nuclei.
In control cells on day 7 in DM, fusion to multinucleated myotubes/myocytes was observed after 12 successive transfection on day 3 with Ad_shSCR ( Fig. 4A, C) . In contrast, the Capn2 knockdown cells showed neither fusion nor differentiation to mature myotubes or myocytes ( Fig. 4B, C ). In addition, there were fewer nuclei and smaller myotubes in Ad_shcapn2 transfected cell cultures compared to the control ( Fig. 4A, B ). Re-transfection of the adenovirus-vector on day 3 after the initial transfection prolonged the RNAi action up to day 7 while maintaining the constant expression of µ-calpain ( Fig. 4D ). Thus, we conclude that the Ad_shcapn2 has strongly inhibited the myoblast fusion and the inhibition was independent of µ-calpain.
Reduced migration and altered morphology after Capn2 knockdown
Calpain-deficient embryonic fibroblasts have been reported not to regulate the membrane protrusion dynamics during fibroblasts migration (19, 20) . To evaluate whether the specific knockdown of Capn2 affects skeletal myoblast migration, we examined cell motility at 3 days after transfection with Ad_shSCR or Ad_shcapn2. Cell movement was analyzed by wound healing assay. An area of a monolayer culture was denuded and the number of cells that traveled toward the acellular front was measured. Neither protein nor activity levels of m-calpain were observed in the C 2 C 12 cells transfected with Ad_shcapn2 for 3 days (data not shown). These cells showed distinctly reduced migration rates, compared with control cells transfected with Ad_shSCR ( Fig. 5 ), providing evidence that m-calpain makes a significant contribution to cell motility. Morphologically, these knockdown cells transfected with Ad_shcapn2 for 3 days revealed numerous membrane protrusions and filopodia at 1 h after the plating (Fig. 6A, B) and maintained 13 the structure up to day 4 after the transfection (Fig. 6C, D) .
Disruption of architecture of cytoskeleton during the myoblast spreading
Functional assessment of m-calpain was applied to the myoblast spreading. The C 2 C 12 cells transfected with Ad_shSCR or Ad_shcapn2 for 3 days were plated on the non-coated chamber slides and monitored from 10 min to 3 h. In the control Ad_shSCR transfected cells, the number of spreading cells gradually increased. In contrast, the cell spreading was delayed in the Ad_shcapn2 transfected cells. A large number of cells kept the round morphology for 3 h. At 3 h after plating, 80.5±3.9% cells had spread in the control slides. However, Capn2 knockdown cells showed a reduced spreading rate (64.3±7.1%, p < 0.01, Fig. 7) . These results indicated that the defect in spreading was related to the inhibition of m-calpain activity.
Furthermore, the distribution of cytoskeleton in Capn2 knockdown cells differed from the control.
To explore whether the knockdown of Capn2 affects the cytoskeletal organization, we plated myoblasts transfected with Ad_shSCR or Ad_shcapn2 for 5 days on the chamber slides and observed the cytoskeleton using double fluorescence microscopy. Actin fibers were visualized with Alexa Fluor ® 594-labeled phalloidin. Vinculin reported to be hydrolyzed with m-calpain (21) was detected using the specific antibody labeled with FITC ( Fig. 8 ). Ad_shSCR transfected cells contained numerous stress fiber-like structures (SFLSs) with focal adhesions. However, Capn2 knockdown cells lost SFLSs, particularly the central SFLSs (Fig. 8D ). We also observed ruffled membranes in the Ad_shcapn2 transfected cells and a loss of vinculin containing focal adhesions at the cell periphery. These findings indicate that m-calpain plays an important role in regulating the localization of actin cytoskeleton and focal adhesion.
Discussion
In the present study, we have generated an in vitro knockdown system for m-calpain to evaluate the physiological effects of decreased m-calpain activity, including muscle-specific differentiation per se from myoblasts to myotubes/myocytes and the general mechanism of cell locomotion via cytoskeletal organization. For the first time, we have demonstrated the following four main results: a) selective loss of m-calpain enzyme and accordingly, its activity; b) the strong inhibition of m-calpain with no direct effect on µ-calpain activity; c) the ceasing of myoblast development to myotubes and/or myocytes; and d) a partial blocking of the locomotion and proliferation (Fig. S1 ) of myoblasts.
In a wide variety of cells such as fibroblasts, myoblasts, endothelial cells, and cancer cells (1, 2, 6, 7, 15, 16, 19, 23, 28, 34, 46) , calpains have been implicated in many aspects of cell physiology including the cell-spreading, migration, and actin remodeling (Table 1) . However, the absence of fully specific calpain inhibitors has so far prevented unambiguous proof of a particular role. Previous methods (6, 7, 13, 14, 28) were insufficient for both qualitative and quantitative purposes, i.e., less specific for discriminating each calpain isoform and not completely suppressing the target calpain in a pin-point manner. Thus, the RNAi strategy which can inhibit each calpain specifically would be a powerful tool to clarify physiological functions.
Despite stable expressions of µand m-calpain ( Fig. 1 and 2) , both activities would be raised during the myoblast fusion, concomitantly with myotube formation and restored after the fusion (8, 11) .
Balances between µ-calpain and its specific inhibitor, calpastatin, or between m-calpain and calpastatin are assumed to determine their net proteolytic activities, when the proteases and inhibitors are freely accessible each other. The temporary diminution in calpastatin allows the activation of calpain and calpain-induced proteolysis, which is required for myoblast fusion (5) . In addition, another mechanisms such as the post-translational modification (39), dissociation and/or translocation from the counterpart (21) might be working for enhancement of the enzyme activity. Furthermore, the expression of µ-calpain was independent of m-calpain, suggesting no crosstalk between these isoforms. In the present study, the increase of µ-calpain activity was seen in Capn2 knockdown cells which recovered m-calpain activity up to 40% at 9 days after transfection (Fig. 2D ). However, no compensation of µ-calpain activity was detectable at 3 days after transfection (Fig. 2B ) and at 7 days after re-transfection ( Fig. 4D) in Capn2 knockdown cells. These data suggest that the expression of µ-calpain is not linked to m-calpain activity.
The activation of m-calpain but not µ-calpain is required for induction of the limited proteolysis of membrane proteins that may be closely related to the myoblast fusion. Overall, m-calpain is essential for muscle cell differentiation, especially during the burst of myoblast fusion at initial stage of differentiation.
On the other hand, previous investigation demonstrated that µ-calpain did not affect myoblast fusion (3).
Thus, these two isozymes might have distinctly different functions.
Interestingly, the phenomena such as fusion or differentiation to mature myotubes were not seen in filamin C (FLNc) knockdown myoblasts as well as Capn2 knockdown myoblasts. FLNc is the muscle-specific member of a family of actin binding proteins. The FLNc knockdown myoblasts display defects in differentiation and fusion ability and ultimately form multinucleated "myoballs" (10) . These data indicate that FLNc is critical for normal myogenesis as well as maintaining the structural integrity of the muscle fibers. Though the causal relation of two similar phenomena is not clear, a number of molecules have been implicated in muscle cell differentiation.
Most studies so far lacked a direct proof that m-calpain, but not µ-calpain, is actually working in myogenesis. Considering intracellular physiological Ca 2+ concentration at submicromolar level (17), m-calpain that requires millimolar Ca 2+ concentration for the full activation leaves us an exciting challenge in muscle biology. Although treatment by several non-specific calpain inhibitors has been reported to suppress the progression of muscle diseases (14) , the responsible calpain has not been identified.
m-calpain plays an indispensable role in murine embryogenesis, possibly related to preimplantation development (16) .
In fibroblasts of Capn4 -/mouse that has lost both µand m-calpain, similar morphological change in
Capn2 knockdown was observed, showing numerous protrusions (15, 19) . These Capn2 knockdown cells had only µ-calpain activity (data not shown). Protrusion may reflect the polymerization of actin filaments at the barbed ends and their formation of a highly branched dendritic network that drives membrane extension at the leading edge of lamellipodia (32) . Huttenlocher's group has indicated that the membrane protrusion is regulated by m-calpain-mediated proteolysis of cortactin in vivo (31, 32) .
Additionally, cortactin may play a key role in the dynamic assembly and disassembly in actin polymerization at the cell periphery (45) . Cleavage of other cytoskeletal proteins, such as talin, spectrin and FAK, has been considered to be responsible for abnormal organization of cytoskeleton. Present finding that knockdown of Capn2 lost SFLSs strongly suggests the involvement of m-calpain among calpain family in SFLSs formation in the myoblasts (33) .
Integrin-mediated motility decreased in Capn4 -/fibroblasts which lack both µand m-calpain (15) and calpain inhibition may negatively modulate cell migration through inhibiting new adhesions and destabilizing the cytoskeleton (13) . We have observed similarly reduced migration in 
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